A new tailored treatment for chronic graft-versus-host disease (chronic GVHD) has won UK approval for the first time, it has been announced.
The treatment is expected to benefit a small number of patients who do not respond to standard treatment....
1 year ago
Scientists have reported new discoveries about how haematopoietic stem cells diversify in the early embryo.
Haematopoietic stem and progenitor cells (HSPCs) in the adult bone marrow are diverse, and produce a number of different cell lineages. Thi...
1 year ago
